Unum Group (UNM) has been in focus after reporting first quarter 2026 results, with revenue of US$3,355.2 million and net income of US$232 million, alongside higher earnings per share versus a year earlier.

At a share price of US$80.29, Unum Group has seen a 30 day share price return of 5.87% and a 90 day share price return of 6.12%. Its 3 year total shareholder return of 96.88% and 5 year total shareholder return of 223.37% point to solid longer term compounding, as the recent earnings and ongoing buybacks shape how investors view both growth prospects and risk.

If Unum Group's mix of earnings momentum and capital returns has caught your attention, it can be useful to see how other insurers stack up on quality and resilience through the solid balance sheet and fundamentals stocks screener (45 results)

With earnings per share running ahead of last year and fresh buybacks shrinking the share count, the key question is whether Unum Group at about US$80 is still undervalued or if the stock already reflects future growth.

Most Popular Narrative: 15.6% Undervalued

With Unum Group's fair value narrative sitting at $95.08 versus a last close of $80.29, the valuation gap centers on how earnings and capital returns play out over time.

Strong capital generation and excess liquidity (including an anticipated holding company cash position of $2 to $2.5 billion) position Unum to sustain elevated levels of shareholder returns through dividends and share buybacks, providing a pathway for EPS growth and continued financial flexibility.

Curious what underpins that valuation gap? The narrative leans on changing margins, steady top line assumptions, and a specific earnings bar that needs to be cleared. The full story connects these moving parts into one price tag.

Result: Fair Value of $95.08 (UNDERVALUED)

However, elevated benefit ratios and ongoing long term care pressures, together with softer sales and investment income, could still challenge the valuation story that is driven by margins and buybacks.

Another Angle Using Market Ratios

While the fair value narrative points to upside, the current P/E of 16.4x sits above both the US Insurance industry at 11.5x and the peer average of 10.6x, and it is also higher than the fair ratio of 15.3x, which suggests less margin for error if sentiment turns.

For a closer look at how this valuation gap might close over time and what it could mean for your risk and return balance, See what the numbers say about this price — find out in our valuation breakdown.

Next Steps

With both risks and rewards on the table, the real question is how you frame the trade off for your own portfolio. If you want to move quickly and base that view on a fuller picture, start by weighing the 4 key rewards and 2 important warning signs

Looking for more investment ideas?

If Unum Group looks interesting, do not stop here. The real edge comes from lining up a few strong candidates and comparing quality, risk, and price side by side.

• Target companies with robust balance sheets by scanning the solid balance sheet and fundamentals stocks screener (45 results) to spot businesses that keep debt and financial risk in check.
• Hunt for potential bargains using the 44 high quality undervalued stocks and see which stocks combine quality metrics with prices that sit below their estimated worth.
• Build a watchlist of steady income ideas through the 12 dividend fortresses and focus on companies offering yields above 5% backed by solid fundamentals.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.